3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Vitamin D Deficiency
3
Prostatic Neoplasms
3
Leukemia, Lymphocytic, Chronic, B-Cell
2
Triple Negative Breast Neoplasms
1
Subcutaneous panniculitis-like T-cell lymphoma
1
Psoriasis
1
Osteoporosis Secondary
1
Osteoarthritis
1
Obesity
1
Neoplasms
1
Lymphoma, T-Cell
1
Lymphoma, Primary Cutaneous Anaplastic Large Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Extranodal NK-T-Cell
1
Immunoblastic Lymphadenopathy
1
Fractures, Stress
1
Enteropathy-Associated T-Cell Lymphoma
1
Colorectal Adenocarcinoma
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Intraductal, Noninfiltrating
1
Bone Metabolism Biomarkers
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Interventions
Cisplatin
6
pembrolizumab
5
Nivolumab
5
palbociclib
4
durvalumab
4
Pemetrexed
4
atezolizumab
3
abemaciclib
3
Fulvestrant
3
Carboplatin
3
Anastrozole
3
130-nm albumin-bound paclitaxel
3
selpercatinib
2
ribociclib
2
relatlimab
2
entrectinib
2
cobimetinib
2
capmatinib
2
alectinib
2
Vemurafenib
2
Radiosurgery
2
Paclitaxel
2
Letrozole
2
Gonadotropin-Releasing Hormone
2
Gemcitabine
2
Bevacizumab
2
AZD9833
2
trametinib
1
taletrectinib
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms by Site
×
Cholecalciferol
×
1 year
×
Clear all
No trials found.